“I think there is a growth in terms of volume, given the kind of appetite that people have for jewellery and also, we feel that you will see stable margins once there is a little bit of stability in the gold prices,” says Hemang Jani, Independent Market Expert.Now Goldman Sachs has come out with a … Read more
Sandip Sabharwal, asksandipsabharwal.com, says “the markets have corrected and people are correlating it to what might happen in the election. I do not think that is the right way to do it. I think markets fall under their own weight when they become overweight. So, the Indian market became overweight and is correcting a bit. … Read more
“You can see from foreign flows perspective that that rebound in China is detracting from some of the investment in India. I do not think it changes the longer-term trends, but we are in one of those holding patterns similar to the fourth quarter of 2023,” says Laurence Balanco, CLSA.What is the take on India … Read more
“It is just that we have a strong domestic investor sentiment and about $2 billion per month is the incremental SIP which I think to an extent is ensuring that markets are not really crashing,” says Sudip Bandyopadhyay, Inditrade Capital. Just wanted to understand from you that from the earnings, which sector that you are … Read more
After the IT sector it was the pharmaceutical sector which came into limelight as another big exporter from India. The valuations exploded and for a decade, pharma stocks were big wealth creators and also strong out performers. However, post 2014, both in terms of bottomline and stock price performance, pharma stocks had been under pressure. … Read more
The government is expected to extend export benefits under the RoDTEP scheme to iron and steel, chemicals and pharmaceutical sectors beyond September 30, according to a senior official. In December 2022, the government extended the benefits under the Remission of Duties and Taxes on Exported Products (RoDTEP) Scheme to chemicals, pharmaceuticals and products of iron … Read more
“Question is whether you will get an allotment or not because of the heavy over subscription. But, from retail investor perspective, it is a good opportunity and perhaps you could even add some stock post listing,” says Dipan Mehta, Director, Elixir Equities.Mankind Pharma, an offering from the pharma sector after a while, wanted to understand … Read more
Pharma funds have been topping the return charts since the Covid-19 pandemic hit the world. The category that invests mostly in the pharmaceutical sector has offered 58.16% returns in one year and 48.25% returns in this year to date, according to Value Research, a mutual fund tracking firm. Among the pharma funds, DSP Healthcare Fund … Read more